Thus, a tumor-targeting drug carrier was constructed via coating PM on Hb-LOX-DOX-encapsulated ZIF8 to regulate the tumor microenvironment and enhance chemotherapy simultaneously by depleting lactate and relieving hypoxia. The gene discussed is GSTM1; the disease is neoplasm.